In our fibrosarcoma model, we only sporadically observed receptor positivity co-localized with CD31 staining; however, a marked effect was found on the vessel network after in vivo TRAIL treatment, although it cannot be excluded that this is an indirect effect caused by the reduced macrophages. Here, PECAM1 is linked to fibrosarcoma.